Yondelis

Product manufactured by Janssen Products, Lp

Application Nr Approved Date Route Status External Links
NDA207953 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Yondelis ® Is Indicated For The Treatment Of Patients With Unresectable Or Metastatic Liposarcoma Or Leiomyosarcoma Who Received A Prior Anthracycline-Containing Regimen [See Clinical Studies (14) ] . Yondelis Is An Alkylating Drug Indicated For The Treatment Of Patients With Unresectable Or Metastatic Liposarcoma Or Leiomyosarcoma Who Received A Prior Anthracycline-Containing Regimen ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Trabectedin TRABECTEDIN ZINC85536982

Comments